These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36935532)

  • 21. Ratio of oxygen saturation index for predicting high-flow nasal cannula outcomes in emergency department for COVID-19 patients with severe hypoxemia: A retrospective study.
    Karam C; Oseili A; Shebbo FM; Fakih M; El-Khatib MF
    Turk J Emerg Med; 2024; 24(1):41-47. PubMed ID: 38343517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
    Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J
    Ther Adv Respir Dis; 2022; 16():17534666221091931. PubMed ID: 35467449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis.
    Yau CE; Lee DYX; Vasudevan A; Goh KJ; Wong E; Ho AFW; Lim DYZ
    Crit Care; 2023 Aug; 27(1):320. PubMed ID: 37605238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study.
    Sudo K; Sawa T; Kushimoto K; Yoshii R; Yuasa K; Inoue K; Kinoshita M; Yamasaki M; Kooguchi K
    PeerJ; 2023; 11():e15174. PubMed ID: 37065694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
    Hu M; Zhou Q; Zheng R; Li X; Ling J; Chen Y; Jia J; Xie C
    BMC Pulm Med; 2020 Dec; 20(1):324. PubMed ID: 33357219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.
    Kwon H; Ha SW; Kim B; Chae B; Kim SM; Hong SI; Kim JS; Kim YJ; Ryoo SM; Kim WY
    Am J Emerg Med; 2024 Jan; 75():53-58. PubMed ID: 37913715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ROX, HROX, and delta-HR indices to predict successful weaning from high-flow oxygen therapy in hospitalized patients with COVID-19 pneumonia.
    Ruchiwit P; Madua J; Saiphoklang N
    PLoS One; 2024; 19(2):e0297624. PubMed ID: 38359052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.
    Basoulis D; Avramopoulos P; Aggelara M; Karamanakos G; Voutsinas PM; Karapanou A; Psichogiou M; Samarkos M; Ntziora F; Sipsas NV
    Can Respir J; 2023; 2023():7474564. PubMed ID: 36817550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Tada Y; Tsushima K
    Respir Investig; 2022 Jan; 60(1):146-153. PubMed ID: 34772644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROX index versus HACOR scale in predicting success and failure of high-flow nasal cannula in the emergency department for patients with acute hypoxemic respiratory failure: a prospective observational study.
    Praphruetkit N; Boonchana N; Monsomboon A; Ruangsomboon O
    Int J Emerg Med; 2023 Jan; 16(1):3. PubMed ID: 36627604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index.
    Li Z; Chen C; Tan Z; Yao Y; Xing S; Li Y; Gao Y; Zhao Z; Deng Y; Zhu M
    BMC Pulm Med; 2022 Jun; 22(1):227. PubMed ID: 35698120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of ROX Index, ROX-HR Index, and SpO
    Choi SH; Kim DY; Song BY; Yoo YS
    J Korean Acad Nurs; 2023 Aug; 53(4):468-479. PubMed ID: 37673820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.
    Ait Hamou Z; Levy N; Charpentier J; Mira JP; Jamme M; Jozwiak M
    Respir Res; 2022 Dec; 23(1):329. PubMed ID: 36463161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.
    Okano H; Yamamoto R; Iwasaki Y; Irimada D; Konno D; Tanaka T; Oishi T; Nawa H; Yano A; Taniguchi H; Otawara M; Matsuoka A; Yamauchi M
    J Intensive Care; 2024 Feb; 12(1):7. PubMed ID: 38360681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure Prediction of High-Flow Nasal Cannula at the Conventional Oxygen Therapy Phase in the Emergency Department.
    Kang Y; Jung HM; Chung SP; Chung HS; Cho Y
    Respiration; 2024 Jun; ():1-8. PubMed ID: 38934166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.
    Zhou X; Liu J; Pan J; Xu Z; Xu J
    BMC Pulm Med; 2022 Apr; 22(1):121. PubMed ID: 35365110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Flow Nasal Cannula for COVID-19 Patients: A Multicenter Retrospective Study in China.
    Duan J; Zeng J; Deng P; Ni Z; Lu R; Xia W; Jing G; Su X; Ehrmann S; Zhang W; Li J
    Front Mol Biosci; 2021; 8():639100. PubMed ID: 33928119
    [No Abstract]   [Full Text] [Related]  

  • 39. dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy.
    Ruchiwit P; Pongtongkam K; Saiphoklang N
    Crit Care Res Pract; 2024; 2024():8880259. PubMed ID: 38450049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations.
    Schaeffer BZ; Fazio SA; Stocking JC; Adams JY; Liu A; Black HB; Harper RW; Cortes-Puch I; Albertson TE; Kuhn BT
    Respir Care; 2024 Apr; ():. PubMed ID: 38653556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.